Mega Genomics Limited (HKG:6667)

Hong Kong · Delayed Price · Currency is HKD

7.19

+0.02 (0.28%)

Sep 11, 2026, 3:51 PM HKT

Mega Genomics Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	358.37	247.15	164.23	151.3	145.73	237.19
Revenue Growth	45.00%	50.49%	8.54%	3.82%	-38.56%	16.71%
Gross Profit	120.9	117.36	119.35	88.3	81.72	166.68
Operating Income	26.09	26.57	48.12	26.71	-24.4	108.69
Net Income	24.51	27.02	45.05	30.04	-17.62	79.02
Earnings Per Share	0.12	0.14	0.22	0.14	-0.09	0.62
EPS Growth	-9.29%	-36.98%	53.11%	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	424.56	438.36	493.16	526.27	408.53	462.63
Total Debt	28.52	29.37	34.4	48.56	10.99	11.57
Net Cash (Debt)	396.04	408.99	458.75	477.71	397.55	451.06
Net Cash Growth	-3.17%	-10.85%	-3.97%	20.16%	-11.86%	135.56%
Net Cash Per Share	2.01	2.07	2.21	2.26	1.93	3.54

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-	-16.52	57.15	163.68	-6.91	30.63
Capital Expenditures	-	-0.16	-0.76	-35.86	-5.01	-4.16
Free Cash Flow	-	-16.68	56.39	127.83	-11.92	26.47
Free Cash Flow Growth	-	-	-55.89%	-	-	-74.00%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	33.74%	47.48%	72.67%	58.36%	56.08%	70.27%
Operating Margin	7.28%	10.75%	29.30%	17.66%	-16.75%	45.83%
Pretax Margin	8.55%	13.28%	32.66%	23.91%	-14.70%	40.42%
Profit Margin	6.84%	10.93%	27.43%	19.85%	-12.09%	33.31%
FCF Margin	-	-6.75%	34.34%	84.49%	-8.18%	11.16%

Dividends

Fiscal Year	Current	FY 2025
Period Ending	Sep '26 Sep 11, 2026	Dec '25 Dec 31, 2025
Dividend Per Share	0.175	0.150
Dividend Per Share Growth	0%	-
Dividend Yield	2.47%	2.38%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	50.03	53.71	52.26	74.01	-	-
Forward PE	-	9.77	9.77	9.77	14.29	-
P/FCF Ratio	-	-	41.74	17.39	-	-
PS Ratio	3.89	5.87	14.33	14.69	18.88	-